The FDA approved berotralstat oral pellets for prophylactic use in patients aged 12 years and older with hereditary ...

In 2022, the proportion of eligible U.S. adults screened for lung cancer was lower than the proportions screened for breast ...

Data linking estrogen-only therapy for menopausal women to a modest increase in autoimmune disease risk, vs.

Among patients with psoriatic disease and overweight or obesity, concomitant ixekizumab and tirzepatide therapy was ...

Patellar resurfacing during total knee replacement may be more economical for patients and healthcare institutions, according to results published in The Lancet.“Although the differences in clinical ...

Women with a history of recurrent urinary tract infections were more likely to report perioperative vaginal estrogen use and ...

Several counterfeit eye drops, some of which were contaminated with bacteria, were recently found in U.S. stores, according ...

The rise of measles cases in the United States has clinical implications for patients prescribed immunosuppressive therapies, ...

Tegoprazan demonstrated significant improvements in 24-hour and nighttime heartburn among patients with nonerosive reflux ...

Lisraya, an oral tyrosine kinase 2/Janus kinase inhibitor, achieved its primary endpoint in two phase 3 clinical trials ...

The FDA has approved Ultomiris to reduce proteinuria in adult patients with primary immunoglobulin A, or IgA, nephropathy who ...

Neutralizing antibodies against measles fell below detectable levels by age 6 months for most infants included in a study ...